ReP USP - Resultado da busca

Artigo de periodico
Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents (2023)
Vassiliades, Sandra Valeria ; Borges, Lara Gimenez; Giarolla, Jeanine ; Parise Filho, Roberto
Source: Mini-Reviews in Medicinal Chemistry. Unidade: FCF
Subjects: HOMEOSTASE, TUBERCULOSE, ÁCIDO FÓLICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VASSILIADES, Sandra Valeria et al. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents. Mini-Reviews in Medicinal Chemistry, v. 23, n. 17, p. 1711-1732, 2023Tradução . . Disponível em: https://doi.org/10.2174/1389557523666230206163154. Acesso em: 25 jun. 2024.
APA
Vassiliades, S. V., Borges, L. G., Giarolla, J., & Parise Filho, R. (2023). Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents. Mini-Reviews in Medicinal Chemistry, 23( 17), 1711-1732. doi:10.2174/1389557523666230206163154
NLM
Vassiliades SV, Borges LG, Giarolla J, Parise Filho R. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents [Internet]. Mini-Reviews in Medicinal Chemistry. 2023 ; 23( 17): 1711-1732.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1389557523666230206163154
Vancouver
Vassiliades SV, Borges LG, Giarolla J, Parise Filho R. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents [Internet]. Mini-Reviews in Medicinal Chemistry. 2023 ; 23( 17): 1711-1732.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1389557523666230206163154
Artigo de periodico
2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations (2023)
Cuppoloni, Andréa; Silva, João Vitor da ; Snape, Timothy James ; Lal, Samridhi ; Giarolla, Jeanine
Source: Current Topics in Medicinal Chemistry. Unidade: FCF
Subjects: MEDICAMENTO, METABOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUPPOLONI, Andréa et al. 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations. Current Topics in Medicinal Chemistry, v. 23, n. 12, p. 1081-1089, 2023Tradução . . Disponível em: https://doi.org/10.2174/1568026623666230207120752. Acesso em: 25 jun. 2024.
APA
Cuppoloni, A., Silva, J. V. da, Snape, T. J., Lal, S., & Giarolla, J. (2023). 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations. Current Topics in Medicinal Chemistry, 23( 12), 1081-1089. doi:10.2174/1568026623666230207120752
NLM
Cuppoloni A, Silva JV da, Snape TJ, Lal S, Giarolla J. 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( 12): 1081-1089.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1568026623666230207120752
Vancouver
Cuppoloni A, Silva JV da, Snape TJ, Lal S, Giarolla J. 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( 12): 1081-1089.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1568026623666230207120752
Artigo de periodico
Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles (2023)
Awasthi, Rajendra ; Singh, Anurag Kumar ; Mishra, Gaurav ; Maurya, Anand ; Dhiman, Neerupma ; Kharkwal, Harsha ; Sharma, Bhupesh ; Jha, Niraj Kumar ; Dua, Kamal ; Pinto, Terezinha de Jesus Andreoli ; Kulkarni, Giriraj T
Source: Letters in Drug Design & Discovery. Unidade: FCF
Subjects: NEOPLASIAS PULMONARES, NANOTECNOLOGIA, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AWASTHI, Rajendra et al. Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles. Letters in Drug Design & Discovery, v. 20, n. 5, p. 499-516, 2023Tradução . . Disponível em: https://doi.org/10.2174/1570180819666220510133408. Acesso em: 25 jun. 2024.
APA
Awasthi, R., Singh, A. K., Mishra, G., Maurya, A., Dhiman, N., Kharkwal, H., et al. (2023). Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles. Letters in Drug Design & Discovery, 20( 5), 499-516. doi:10.2174/1570180819666220510133408
NLM
Awasthi R, Singh AK, Mishra G, Maurya A, Dhiman N, Kharkwal H, Sharma B, Jha NK, Dua K, Pinto T de JA, Kulkarni GT. Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles [Internet]. Letters in Drug Design & Discovery. 2023 ; 20( 5): 499-516.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1570180819666220510133408
Vancouver
Awasthi R, Singh AK, Mishra G, Maurya A, Dhiman N, Kharkwal H, Sharma B, Jha NK, Dua K, Pinto T de JA, Kulkarni GT. Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles [Internet]. Letters in Drug Design & Discovery. 2023 ; 20( 5): 499-516.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1570180819666220510133408
Artigo de periodico
Cruzain inhibitors: state-of-art of novel synthetic strategies (2023)
Morais, Pedro Alves Bezerra ; Trossini, Gustavo Henrique Goulart
Source: Current Organic Chemistry. Unidade: FCF
Subjects: DOENÇA DE CHAGAS, SÍNTESE ORGÂNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAIS, Pedro Alves Bezerra e TROSSINI, Gustavo Henrique Goulart. Cruzain inhibitors: state-of-art of novel synthetic strategies. Current Organic Chemistry, v. 27, n. 4, p. 243-247, 2023Tradução . . Disponível em: https://doi.org/10.2174/1385272827666230418100932. Acesso em: 25 jun. 2024.
APA
Morais, P. A. B., & Trossini, G. H. G. (2023). Cruzain inhibitors: state-of-art of novel synthetic strategies. Current Organic Chemistry, 27( 4), 243-247. doi:10.2174/1385272827666230418100932
NLM
Morais PAB, Trossini GHG. Cruzain inhibitors: state-of-art of novel synthetic strategies [Internet]. Current Organic Chemistry. 2023 ; 27( 4): 243-247.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1385272827666230418100932
Vancouver
Morais PAB, Trossini GHG. Cruzain inhibitors: state-of-art of novel synthetic strategies [Internet]. Current Organic Chemistry. 2023 ; 27( 4): 243-247.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1385272827666230418100932
Artigo de periodico-carta/editorial
Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial] (2022)
Pone, Boniface Kamdem ; Ferreira, Elizabeth Igne
Source: Current Drug Targets. Unidade: FCF
Subjects: FLAVONOIDES, MEDICAMENTO, DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONE, Boniface Kamdem e FERREIRA, Elizabeth Igne. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial]. Current Drug Targets. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.2174/1389450123666220309093827. Acesso em: 25 jun. 2024. , 2022
APA
Pone, B. K., & Ferreira, E. I. (2022). Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial]. Current Drug Targets. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.2174/1389450123666220309093827
NLM
Pone BK, Ferreira EI. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial] [Internet]. Current Drug Targets. 2022 ; 23( 7): 680-682.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1389450123666220309093827
Vancouver
Pone BK, Ferreira EI. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial] [Internet]. Current Drug Targets. 2022 ; 23( 7): 680-682.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1389450123666220309093827
Artigo de periodico
Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development (2022)
Pone, Kamdem Boniface ; Dalhatou, Sadou; Paumo, Hugues Kamdem ; Seru, Lebogang Maureen Katata ; Ferreira, Elizabeth Igne
Source: Current Drug Targets. Unidade: FCF
Subjects: TRYPANOSOMA CRUZI, COMPOSTOS HETEROCÍCLICOS, ANTIPROTOZOÁRIOS, DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONE, Kamdem Boniface et al. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development. Current Drug Targets, v. 23, n. 1, p. 33-59, 2022Tradução . . Disponível em: https://doi.org/10.2174/1389450122666210412125643. Acesso em: 25 jun. 2024.
APA
Pone, K. B., Dalhatou, S., Paumo, H. K., Seru, L. M. K., & Ferreira, E. I. (2022). Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development. Current Drug Targets, 23( 1), 33-59. doi:10.2174/1389450122666210412125643
NLM
Pone KB, Dalhatou S, Paumo HK, Seru LMK, Ferreira EI. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development [Internet]. Current Drug Targets. 2022 ; 23( 1): 33-59.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1389450122666210412125643
Vancouver
Pone KB, Dalhatou S, Paumo HK, Seru LMK, Ferreira EI. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development [Internet]. Current Drug Targets. 2022 ; 23( 1): 33-59.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1389450122666210412125643
Artigo de periodico
The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds (2021)
Boniface, Pone Kamdem ; Ferreira, Elizabeth Igne
Source: Current Drug Targets. Unidade: FCF
Subjects: DOENÇAS NEGLIGENCIADAS, ANTIMALÁRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFACE, Pone Kamdem e FERREIRA, Elizabeth Igne. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds. Current Drug Targets, v. 22, p. 379-398, 2021Tradução . . Disponível em: https://doi.org/10.2174/1389450121666201228122239. Acesso em: 25 jun. 2024.
APA
Boniface, P. K., & Ferreira, E. I. (2021). The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds. Current Drug Targets, 22, 379-398. doi:10.2174/1389450121666201228122239
NLM
Boniface PK, Ferreira EI. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds [Internet]. Current Drug Targets. 2021 ; 22 379-398.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1389450121666201228122239
Vancouver
Boniface PK, Ferreira EI. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds [Internet]. Current Drug Targets. 2021 ; 22 379-398.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1389450121666201228122239
Artigo de periodico
Insights into newly approved drugs from a medicinal chemistry perspective (2021)
Lima, Elys Juliane Cardoso ; Gomes, Renan Augusto ; Fornari, Evelin; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart
Source: Mini-Reviews in Medicinal Chemistry. Unidades: FCFRP, FCF
Assunto: FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Elys Juliane Cardoso et al. Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, v. 21, n. 16, p. 2227-2248, 2021Tradução . . Disponível em: https://doi.org/10.2174/1389557521666210226145328. Acesso em: 25 jun. 2024.
APA
Lima, E. J. C., Gomes, R. A., Fornari, E., Emery, F. da S., & Trossini, G. H. G. (2021). Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, 21( 16), 2227-2248. doi:10.2174/1389557521666210226145328
NLM
Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1389557521666210226145328
Vancouver
Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1389557521666210226145328
Artigo de periodico
Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis (2021)
Primi, Marina Candido ; Tavares, Maurício Temotheo ; Klein, Larry L; Izard, Tina; Sant'Anna, Carlos M. R; Franzblau, Scott Gary; Ferreira, Elizabeth Igne
Source: Current Topics in Medicinal Chemistry. Unidade: FCF
Subjects: TUBERCULOSE, ANTIBIÓTICOS, INIBIDORES DE ENZIMAS, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRIMI, Marina Candido et al. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis. Current Topics in Medicinal Chemistry, v. 21, p. 1186-1197, 2021Tradução . . Disponível em: https://doi.org/10.2174/1568026621666210728094804. Acesso em: 25 jun. 2024.
APA
Primi, M. C., Tavares, M. T., Klein, L. L., Izard, T., Sant'Anna, C. M. R., Franzblau, S. G., & Ferreira, E. I. (2021). Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis. Current Topics in Medicinal Chemistry, 21, 1186-1197. doi:10.2174/1568026621666210728094804
NLM
Primi MC, Tavares MT, Klein LL, Izard T, Sant'Anna CMR, Franzblau SG, Ferreira EI. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 1186-1197.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1568026621666210728094804
Vancouver
Primi MC, Tavares MT, Klein LL, Izard T, Sant'Anna CMR, Franzblau SG, Ferreira EI. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 1186-1197.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1568026621666210728094804
Artigo de periodico
Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review (2021)
Prasher, Parteek ; Sharma, Mousmee ; Zacconi, Flavia ; Gupt, Gaurav ; Aljabali, Alaa A ; Mishra, Vijay ; Tambuwala, Murtaza M ; Kapoor, Deepak N ; Negi, Poonam ; Pinto, Terezinha de Jesus Andreoli ; Singh, Inderbir ; Chellappan, Dinesh Kumar ; Dua, Kamal
Source: Current Organic Chemistry. Unidade: FCF
Subjects: QUIMIOTERÁPICOS, COMPOSTOS HETEROCÍCLICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRASHER, Parteek et al. Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review. Current Organic Chemistry, v. 25, p. 654-668, 2021Tradução . . Disponível em: https://doi.org/10.2174/1385272824999200820152501. Acesso em: 25 jun. 2024.
APA
Prasher, P., Sharma, M., Zacconi, F., Gupt, G., Aljabali, A. A., Mishra, V., et al. (2021). Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review. Current Organic Chemistry, 25, 654-668. doi:10.2174/1385272824999200820152501
NLM
Prasher P, Sharma M, Zacconi F, Gupt G, Aljabali AA, Mishra V, Tambuwala MM, Kapoor DN, Negi P, Pinto T de JA, Singh I, Chellappan DK, Dua K. Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review [Internet]. Current Organic Chemistry. 2021 ; 25 654-668.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1385272824999200820152501
Vancouver
Prasher P, Sharma M, Zacconi F, Gupt G, Aljabali AA, Mishra V, Tambuwala MM, Kapoor DN, Negi P, Pinto T de JA, Singh I, Chellappan DK, Dua K. Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review [Internet]. Current Organic Chemistry. 2021 ; 25 654-668.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1385272824999200820152501
Artigo de periodico
Design of arylsulfonylhydrazones as potential FabH inhibitors: synthesis, antimicrobial evaluation and molecular docking (2021)
Fernandes, Thais Batista; Segretti, Natanael Dante; Lourenço, Felipe Rebello ; Cândido, Thalita Marcílio ; Baby, André Rolim ; Barbosa, Euzébio Guimarães ; Parise Filho, Roberto
Source: Medicinal Chemistry. Unidade: FCF
Subjects: AGENTES ANTIMICROBIANOS, ANTIOXIDANTES, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Thais Batista et al. Design of arylsulfonylhydrazones as potential FabH inhibitors: synthesis, antimicrobial evaluation and molecular docking. Medicinal Chemistry, v. 17, p. 474-484, 2021Tradução . . Disponível em: https://doi.org/10.2174/1573406415666191122111228. Acesso em: 25 jun. 2024.
APA
Fernandes, T. B., Segretti, N. D., Lourenço, F. R., Cândido, T. M., Baby, A. R., Barbosa, E. G., & Parise Filho, R. (2021). Design of arylsulfonylhydrazones as potential FabH inhibitors: synthesis, antimicrobial evaluation and molecular docking. Medicinal Chemistry, 17, 474-484. doi:10.2174/1573406415666191122111228
NLM
Fernandes TB, Segretti ND, Lourenço FR, Cândido TM, Baby AR, Barbosa EG, Parise Filho R. Design of arylsulfonylhydrazones as potential FabH inhibitors: synthesis, antimicrobial evaluation and molecular docking [Internet]. Medicinal Chemistry. 2021 ; 17 474-484.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1573406415666191122111228
Vancouver
Fernandes TB, Segretti ND, Lourenço FR, Cândido TM, Baby AR, Barbosa EG, Parise Filho R. Design of arylsulfonylhydrazones as potential FabH inhibitors: synthesis, antimicrobial evaluation and molecular docking [Internet]. Medicinal Chemistry. 2021 ; 17 474-484.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1573406415666191122111228
Artigo de periodico
An insight into the discovery of potent Antifilarial leads against lymphatic filariasis (2020)
Boniface, Pone Kamdem ; Ferreira, Elizabeth Igne
Source: Current Drug Targets. Unidade: FCF
Subjects: FILARIOSE, DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFACE, Pone Kamdem e FERREIRA, Elizabeth Igne. An insight into the discovery of potent Antifilarial leads against lymphatic filariasis. Current Drug Targets, v. 21, p. 657-680, 2020Tradução . . Disponível em: https://doi.org/10.2174/1389450120666191204152415. Acesso em: 25 jun. 2024.
APA
Boniface, P. K., & Ferreira, E. I. (2020). An insight into the discovery of potent Antifilarial leads against lymphatic filariasis. Current Drug Targets, 21, 657-680. doi:10.2174/1389450120666191204152415
NLM
Boniface PK, Ferreira EI. An insight into the discovery of potent Antifilarial leads against lymphatic filariasis [Internet]. Current Drug Targets. 2020 ; 21 657-680.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1389450120666191204152415
Vancouver
Boniface PK, Ferreira EI. An insight into the discovery of potent Antifilarial leads against lymphatic filariasis [Internet]. Current Drug Targets. 2020 ; 21 657-680.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1389450120666191204152415
Artigo de periodico
Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods (2020)
Boniface, Pone Kamdem ; Sano, Cinthya Miyuki; Ferreira, Elizabeth Igne
Source: Current Drug Targets. Unidade: FCF
Subjects: LEISHMANIA, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFACE, Pone Kamdem e SANO, Cinthya Miyuki e FERREIRA, Elizabeth Igne. Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods. Current Drug Targets, v. 21, p. 681-712, 2020Tradução . . Disponível em: https://doi.org/10.2174/1389450121666200128112948. Acesso em: 25 jun. 2024.
APA
Boniface, P. K., Sano, C. M., & Ferreira, E. I. (2020). Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods. Current Drug Targets, 21, 681-712. doi:10.2174/1389450121666200128112948
NLM
Boniface PK, Sano CM, Ferreira EI. Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods [Internet]. Current Drug Targets. 2020 ; 21 681-712.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1389450121666200128112948
Vancouver
Boniface PK, Sano CM, Ferreira EI. Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods [Internet]. Current Drug Targets. 2020 ; 21 681-712.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1389450121666200128112948
Artigo de periodico
Future and perspectives of the Zika Virus: drug repurposing as a powerful tool for treatment insights (2020)
Rampini, Denise ; Prieto, Diego Campos ; Colzi, Ana Luisa; Araujo, Renan Vinicius de ; Giarolla, Jeanine
Source: Mini-Reviews in Medicinal Chemistry. Unidade: FCF
Subjects: ZIKA VÍRUS, SAÚDE PÚBLICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMPINI, Denise et al. Future and perspectives of the Zika Virus: drug repurposing as a powerful tool for treatment insights. Mini-Reviews in Medicinal Chemistry, v. 20, p. 1917-1928, 2020Tradução . . Disponível em: https://doi.org/10.2174/1389557520666200711174007. Acesso em: 25 jun. 2024.
APA
Rampini, D., Prieto, D. C., Colzi, A. L., Araujo, R. V. de, & Giarolla, J. (2020). Future and perspectives of the Zika Virus: drug repurposing as a powerful tool for treatment insights. Mini-Reviews in Medicinal Chemistry, 20, 1917-1928. doi:10.2174/1389557520666200711174007
NLM
Rampini D, Prieto DC, Colzi AL, Araujo RV de, Giarolla J. Future and perspectives of the Zika Virus: drug repurposing as a powerful tool for treatment insights [Internet]. Mini-Reviews in Medicinal Chemistry. 2020 ; 20 1917-1928.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1389557520666200711174007
Vancouver
Rampini D, Prieto DC, Colzi AL, Araujo RV de, Giarolla J. Future and perspectives of the Zika Virus: drug repurposing as a powerful tool for treatment insights [Internet]. Mini-Reviews in Medicinal Chemistry. 2020 ; 20 1917-1928.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1389557520666200711174007
Artigo de periodico-carta/editorial
Drug design and development for neglected diseases [Editorial] (2019)
Ferreira, Elizabeth Igne
Source: Current Medicinal Chemistry. Unidade: FCF
Assunto: DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Elizabeth Igne. Drug design and development for neglected diseases [Editorial]. Current Medicinal Chemistry. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.2174/092986732623190927101548. Acesso em: 25 jun. 2024. , 2019
APA
Ferreira, E. I. (2019). Drug design and development for neglected diseases [Editorial]. Current Medicinal Chemistry. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.2174/092986732623190927101548
NLM
Ferreira EI. Drug design and development for neglected diseases [Editorial] [Internet]. Current Medicinal Chemistry. 2019 ; 26( 23): 4298-4300.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/092986732623190927101548
Vancouver
Ferreira EI. Drug design and development for neglected diseases [Editorial] [Internet]. Current Medicinal Chemistry. 2019 ; 26( 23): 4298-4300.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/092986732623190927101548
Artigo de periodico
Identification, characterization and molecular modelling studies of schistosoma mansoni dihydrofolate reductase inhibitors: From assay development to hit identification (2018)
Teles, Andre Lacerda Braga; Silva, Roseane R; Ko, Michelle; Ferreira, Glaucio Monteiro; Pita, Samuel da Rocha; Trossini, Gustavo Henrique Goulart ; Carvalho, Paulo; Castilho, Marcelo Santos
Source: Current Topics in Medicinal Chemistry. Unidade: FCF
Subjects: MODELAGEM MOLECULAR, SCHISTOSOMA MANSONI
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TELES, Andre Lacerda Braga et al. Identification, characterization and molecular modelling studies of schistosoma mansoni dihydrofolate reductase inhibitors: From assay development to hit identification. Current Topics in Medicinal Chemistry, v. 18, p. 406-417, 2018Tradução . . Disponível em: https://doi.org/10.2174/1568026618666180509150134. Acesso em: 25 jun. 2024.
APA
Teles, A. L. B., Silva, R. R., Ko, M., Ferreira, G. M., Pita, S. da R., Trossini, G. H. G., et al. (2018). Identification, characterization and molecular modelling studies of schistosoma mansoni dihydrofolate reductase inhibitors: From assay development to hit identification. Current Topics in Medicinal Chemistry, 18, 406-417. doi:10.2174/1568026618666180509150134
NLM
Teles ALB, Silva RR, Ko M, Ferreira GM, Pita S da R, Trossini GHG, Carvalho P, Castilho MS. Identification, characterization and molecular modelling studies of schistosoma mansoni dihydrofolate reductase inhibitors: From assay development to hit identification [Internet]. Current Topics in Medicinal Chemistry. 2018 ; 18 406-417.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1568026618666180509150134
Vancouver
Teles ALB, Silva RR, Ko M, Ferreira GM, Pita S da R, Trossini GHG, Carvalho P, Castilho MS. Identification, characterization and molecular modelling studies of schistosoma mansoni dihydrofolate reductase inhibitors: From assay development to hit identification [Internet]. Current Topics in Medicinal Chemistry. 2018 ; 18 406-417.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1568026618666180509150134
Artigo de periodico
Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells (2018)
Fernandes, Thais Batista; Azevedo, Ricardo Alexandre de; Yang, Rosania; Teixeira, Sarah Fernandes; Trossini, Gustavo Henrique Goulart ; Barbuto, José Alexandre Marzagão ; Ferreira, Adilson Kleber; Parise Filho, Roberto
Source: Letters in Drug Design and Discovery. Unidades: FCF, ICB
Subjects: APOPTOSE, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Thais Batista et al. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells. Letters in Drug Design and Discovery, v. 15, n. 12, p. 1288-1298, 2018Tradução . . Disponível em: https://doi.org/10.2174/1570180815666180321161513. Acesso em: 25 jun. 2024.
APA
Fernandes, T. B., Azevedo, R. A. de, Yang, R., Teixeira, S. F., Trossini, G. H. G., Barbuto, J. A. M., et al. (2018). Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells. Letters in Drug Design and Discovery, 15( 12), 1288-1298. doi:10.2174/1570180815666180321161513
NLM
Fernandes TB, Azevedo RA de, Yang R, Teixeira SF, Trossini GHG, Barbuto JAM, Ferreira AK, Parise Filho R. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells [Internet]. Letters in Drug Design and Discovery. 2018 ; 15( 12): 1288-1298.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1570180815666180321161513
Vancouver
Fernandes TB, Azevedo RA de, Yang R, Teixeira SF, Trossini GHG, Barbuto JAM, Ferreira AK, Parise Filho R. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells [Internet]. Letters in Drug Design and Discovery. 2018 ; 15( 12): 1288-1298.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1570180815666180321161513
Artigo de periodico
Advances and challenges in drug design of PPARδ ligands (2018)
Maltarollo, Vinícius Gonçalves ; Kronenberger, Thales ; Windshuegel, Bjoern ; Wrenger, Carsten ; Trossini, Gustavo Henrique Goulart ; Honório, Káthia Maria
Source: Current Drug Targets. Unidades: ICB, FCF, EACH
Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, SÍNDROME X METABÓLICA, ÁCIDOS GRAXOS, DOENÇAS METABÓLICAS, PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTAROLLO, Vinícius Gonçalves et al. Advances and challenges in drug design of PPARδ ligands. Current Drug Targets, v. 19, n. 2, p. 144-154, 2018Tradução . . Disponível em: https://doi.org/10.2174/1389450118666170414113159. Acesso em: 25 jun. 2024.
APA
Maltarollo, V. G., Kronenberger, T., Windshuegel, B., Wrenger, C., Trossini, G. H. G., & Honório, K. M. (2018). Advances and challenges in drug design of PPARδ ligands. Current Drug Targets, 19( 2), 144-154. doi:10.2174/1389450118666170414113159
NLM
Maltarollo VG, Kronenberger T, Windshuegel B, Wrenger C, Trossini GHG, Honório KM. Advances and challenges in drug design of PPARδ ligands [Internet]. Current Drug Targets. 2018 ; 19( 2): 144-154.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1389450118666170414113159
Vancouver
Maltarollo VG, Kronenberger T, Windshuegel B, Wrenger C, Trossini GHG, Honório KM. Advances and challenges in drug design of PPARδ ligands [Internet]. Current Drug Targets. 2018 ; 19( 2): 144-154.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1389450118666170414113159
Artigo de periodico
Synthesis of a Tyr-Tyr dipeptide library and evaluation against tumor cells (2018)
Vasconcelos, Stanley Nunes Siqueira ; Sciani, Juliana Mozer ; Lisboa, Nicole Mambeli; Stefani, Hélio Alexandre
Source: Medicinal Chemistry. Unidade: FCF
Subjects: MOLÉCULA, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VASCONCELOS, Stanley Nunes Siqueira et al. Synthesis of a Tyr-Tyr dipeptide library and evaluation against tumor cells. Medicinal Chemistry, v. 14, n. 7, p. 709-714, 2018Tradução . . Disponível em: https://doi.org/10.2174/1573406414666180309153142. Acesso em: 25 jun. 2024.
APA
Vasconcelos, S. N. S., Sciani, J. M., Lisboa, N. M., & Stefani, H. A. (2018). Synthesis of a Tyr-Tyr dipeptide library and evaluation against tumor cells. Medicinal Chemistry, 14( 7), 709-714. doi:10.2174/1573406414666180309153142
NLM
Vasconcelos SNS, Sciani JM, Lisboa NM, Stefani HA. Synthesis of a Tyr-Tyr dipeptide library and evaluation against tumor cells [Internet]. Medicinal Chemistry. 2018 ; 14( 7): 709-714.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1573406414666180309153142
Vancouver
Vasconcelos SNS, Sciani JM, Lisboa NM, Stefani HA. Synthesis of a Tyr-Tyr dipeptide library and evaluation against tumor cells [Internet]. Medicinal Chemistry. 2018 ; 14( 7): 709-714.[citado 2024 jun. 25 ] Available from: https://doi.org/10.2174/1573406414666180309153142
Artigo de periodico
Hydrogel based drug delivery systems: a review with special emphasis on challenges associated with decontamination of hydrogels and biomaterials (2017)
Kikuchi, Irene Satiko ; Galante, Raquel Sofia Cardoso; Dua, Kamal; Malipeddi, Venkata Ramana; Ghisleni, Daniela Dal Molim; Pinto, Terezinha de Jesus Andreoli
Source: Current Drug Delivery. Unidade: FCF
Subjects: BIOMATERIAIS, ESTERILIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KIKUCHI, Irene Satiko et al. Hydrogel based drug delivery systems: a review with special emphasis on challenges associated with decontamination of hydrogels and biomaterials. Current Drug Delivery, v. 14, n. 7, p. 917-925, 2017Tradução . . Acesso em: 25 jun. 2024.
APA
Kikuchi, I. S., Galante, R. S. C., Dua, K., Malipeddi, V. R., Ghisleni, D. D. M., & Pinto, T. de J. A. (2017). Hydrogel based drug delivery systems: a review with special emphasis on challenges associated with decontamination of hydrogels and biomaterials. Current Drug Delivery, 14( 7), 917-925.
NLM
Kikuchi IS, Galante RSC, Dua K, Malipeddi VR, Ghisleni DDM, Pinto T de JA. Hydrogel based drug delivery systems: a review with special emphasis on challenges associated with decontamination of hydrogels and biomaterials. Current Drug Delivery. 2017 ; 14( 7): 917-925.[citado 2024 jun. 25 ]
Vancouver
Kikuchi IS, Galante RSC, Dua K, Malipeddi VR, Ghisleni DDM, Pinto T de JA. Hydrogel based drug delivery systems: a review with special emphasis on challenges associated with decontamination of hydrogels and biomaterials. Current Drug Delivery. 2017 ; 14( 7): 917-925.[citado 2024 jun. 25 ]

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration